[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account
arrow_back

Go back to trials list

Erector Spinae Blocks for Thoracic Surgery


Description

The aim of this study is to determine if erector spinae injections with bolus infusions with local anesthetic decrease postsurgical pain and opioid consumption in patients undergoing pulmonary resection surgery.The research hypothesis for the ESB Thoracic study is that erector spinae blocks with boluses of bupivacaine infusions will decrease patients' postsurgical pain, and thereby decrease the amount of narcotic pain medication used. This will be of particular use in patients who have an anticoagulation need and are not able to receive more invasive nerve blocks.To achieve appropriate exposure for pulmonary resection surgery, whether open or video-assisted, patients have surgical incision in the lateral thoracic region, including disruption to the tributaries of the spinal nerves. Due to this dissection, patients frequently experience significant pain post-operatively. Erector spinae blocks with bupivacaine or ropivacaine with bolus infusion therapy have been shown to treat this spina

Trial Eligibility

Inclusion Criteria: * pulmonary resection * 18\<age\<90 Exclusion Criteria: * pleurodesis * decortication * emergent surgery * local anesthetic allergy * intraoperative complication (inadvertent hemorrhage or conversion to open surgery) * bilateral pulmonary resection

Study Info

Organization

George Washington University


Primary Outcome

Outcome Measure - Pain Score and Pain Medications (6 hours)


Outcome Timeframe At 6 hours postoperatively

NCTID NCT05521789

Phases PHASE4

Primary Purpose TREATMENT

Start Date 2022-07-22

Completion Date 2025-07-21

Enrollment Target 70

Interventions

DRUG ESB Thoracic

Locations Recruiting

The George Washington University

United States, District of Columbia, Washington


Interested in joining this trial?

Our dedicated patient navigators are here to support you by reviewing the eligibility criteria to see if you might qualify for this trial.

newsletter icon

Get the latest thought leadership on your Blood Cancer delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.